These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38793547)
1. Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin. Manca V; Chianese A; Palmas V; Etzi F; Zannella C; Moi D; Secci F; Serreli G; Sarais G; Morone MV; Galdiero M; Onnis V; Manzin A; Sanna G Viruses; 2024 Apr; 16(5):. PubMed ID: 38793547 [TBL] [Abstract][Full Text] [Related]
2. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914 [TBL] [Abstract][Full Text] [Related]
3. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT mBio; 2021 Jan; 12(1):. PubMed ID: 33468703 [TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus. Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529 [TBL] [Abstract][Full Text] [Related]
5. In vitro assessment of the antiviral potential of trans-cinnamic acid, quercetin and morin against equid herpesvirus 1. Gravina HD; Tafuri NF; Silva Júnior A; Fietto JL; Oliveira TT; Diaz MA; Almeida MR Res Vet Sci; 2011 Dec; 91(3):e158-62. PubMed ID: 21159355 [TBL] [Abstract][Full Text] [Related]
6. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299 [TBL] [Abstract][Full Text] [Related]
7. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596 [TBL] [Abstract][Full Text] [Related]
8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
9. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752 [TBL] [Abstract][Full Text] [Related]
11. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro. Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661 [TBL] [Abstract][Full Text] [Related]
12. Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors. Ghosh AK; Shahabi D; Yadav M; Kovela S; Anson BJ; Lendy EK; Bonham C; Sirohi D; Brito-Sierra CA; Hattori SI; Kuhn R; Mitsuya H; Mesecar AD Molecules; 2021 Sep; 26(19):. PubMed ID: 34641337 [TBL] [Abstract][Full Text] [Related]
13. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455 [TBL] [Abstract][Full Text] [Related]
14. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo. Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611 [TBL] [Abstract][Full Text] [Related]
15. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis. Keiser PT; Zhang W; Ricca M; Wacquiez A; Grimins A; Cencic R; Patten JJ; Shah P; Padilha E; Connor JH; Pelletier J; Lyons SM; Saeed M; Brown LE; Porco JA; Davey RA Antiviral Res; 2024 Oct; 230():105976. PubMed ID: 39117283 [TBL] [Abstract][Full Text] [Related]
16. Lectin from Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545 [TBL] [Abstract][Full Text] [Related]
17. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2. Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208 [TBL] [Abstract][Full Text] [Related]
18. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses. Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J ACS Infect Dis; 2021 Mar; 7(3):586-597. PubMed ID: 33645977 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of itraconazole against SARS-CoV-2. Van Damme E; De Meyer S; Bojkova D; Ciesek S; Cinatl J; De Jonghe S; Jochmans D; Leyssen P; Buyck C; Neyts J; Van Loock M J Med Virol; 2021 Jul; 93(7):4454-4460. PubMed ID: 33666253 [TBL] [Abstract][Full Text] [Related]
20. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]